Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Comparing High Flow Nasal Cannula and Non-Invasive Ventilation for COPD Exacerbations

Official title: High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease and Hypercapnic Respiratory Failure

Run by Unity Health Toronto · NCT03033251 · Data updated 2026-11-12

This study is testing whether High Flow Nasal Cannula or Non-Invasive Ventilation works better to help people with COPD feel more comfortable and breathe easier during flare-ups.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment30 (estimated)
SponsorUnity Health Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedSeptember 2, 2018
Main results expectedApril 11, 2025
Study endsJuly 1, 2026
Registry record updatedMay 20, 2025
Trial IDNCT03033251 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 40 years old with COPD exacerbation and acute hypercapnic respiratory failure.

Probably not a fit

Patients requiring urgent intubation or those with severe respiratory acidosis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of High Flow Nasal Cannula (HFNC) compared to Non-Invasive Ventilation (NIV) in patients experiencing exacerbations of Chronic Obstructive Pulmonary Disease (COPD) and acute hypercapnic respiratory failure. Participants will be randomly assigned to receive both treatments in a controlled setting, with each intervention lasting up to 30 minutes. The study aims to assess the physiological responses and tolerability of each method in a Medical-Surgical ICU environment. The primary focus is on improving patient comfort and respiratory function during acute episodes.

Why it matters

Potential benefit: If successful, this study could provide a more comfortable and effective method for managing acute respiratory distress in COPD patients.

How similar studies have gone: Previous studies have shown promising results with HFNC in similar patient populations, suggesting potential benefits over traditional NIV.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. COPD exacerbation and acute hypercapnic respiratory failure with acute respiratory failure defined by

   * Respiratory acidosis (pH ≤7.35 and PaCO2 ≥45 mmHg);
   * Respiratory rate≥20 breaths/min;
   * Activation of accessory respiratory muscles;
2. Undergone at NIV or HFNC since their admission
3. English speaking
4. Adult patient with age \> 40 year old.

Exclusion Criteria:

1. Severe respiratory acidosis defined by pH\<7.25
2. Decreased level of consciousness (Glasgow Coma Score Scale \< 11)
3. Urgent intubation required
4. Pneumothorax with pleural drainage and persistent air leak
5. Hemodynamic instability requiring vasopressors
6. Uncooperative
7. Patients with skin or chest wall or abdominal trauma (potentially worsened by placement of a surface sensor)
8. Clinical judgement of the attending physician
9. Body mass index \> 40 kg/m2

Where it's running

  • St. Michael's Hospital
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.